1. Memorial Sloan Kettering Cancer Center, New York, NY;
2. Weill Cornell Medical College, New York, NY;
3. The University of Texas MD Anderson Cancer Center, Houston, TX;
4. Division of Hematology, University of Colorado School of Medicine, Aurora, CO;
5. Massachusetts General Hospital Cancer Center, Boston, MA;
6. Department of Medicine, Harvard Medical School, Boston, MA;
7. New York Presbyterian Hospital, New York, NY;
8. Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL;
9. Dana-Farber Cancer Institute, Boston, MA;
10. Sarah Cannon Research Institute, Nashville, TN;
11. University of Texas Southwestern Medical Center, Dallas, TX;
12. Florida Cancer Specialists and Sarah Cannon Research Institute, Sarasota, FL;
13. City of Hope Comprehensive Cancer Center, Duarte, CA;
14. Cleveland Clinic Taussig Cancer Institute, Cleveland, OH;
15. Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL;
16. Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA;
17. Département d’Hématologie et Département d’Innovation Thérapeutique, Gustave Roussy, Villejuif, France;
18. University Paris Sud and Université Paris-Saclay, Le Kremlin-Bicêtre, France;
19. Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom;
20. National Institute for Health Research Oxford Biomedical Research Center, Oxford University Hospital, Oxford, United Kingdom;
21. Celgene Corporation, Summit, NJ; and
22. Agios Pharmaceuticals, Inc., Cambridge, MA